POP Biotechnologies
Unleash your inner particle. Test POP BIO's next-generation SNAP adjuvant system. Contact [email protected] for samples.
Founded 2015
Buffalo, United States
7 employees
Seed
Total: $4.70M
Biotechnology, Health Care +1
Buffalo, United States
7 employees
Seed
Total: $4.70M
Biotechnology, Health Care +1
General Information
Company Name
POP Biotechnologies
Founded Year
2015
Location
Buffalo, United States
Buffalo, United States
Employees
7
Industries
Biotechnology, Health Care, Life Sciences
Funding Stage
Seed
BounceWatch is an independent company data service, not affiliated with POP Biotechnologies. To contact POP Biotechnologies, visit pop.bio.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
United States Market
Biotechnology
About POP Biotechnologies
Taxonomy: Nanotechnologies, Biomedical, Nanomedicine, Drug Delivery, Chemotherapy, Oncology, Targeted Therapeutics, Innovation, Life Sciences, Buffalo NY, Adjuvant System, Medical Solutions, SNAP Technology
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed Round | $4.00M | - |
|
29 Jul 2021 |
| Grant | $600.00K | 1 |
National Institutes of Health
|
29 Oct 2019 |
| Seed Round | $100.00K | 3 |
|
13 Dec 2016 |
POP Biotechnologies Alternatives & Competitors
View All Alternatives
POP Biotechnologies vs
POP Biotechnologies vs
Cytimmune Sciences
United States
Developing safer more effective therapies that can attack tumors on multiple fronts simultaneously.
Venture round
6 employees
Biotechnology, Health Care
POP Biotechnologies vs
-Limited-and-part-of-Midatech-Pharma-plc-logo.jpg "Q Chip Ltd - Now Midatech Pharma (Wales) Limited and part of Midatech Pharma plc"){kind=logo}
Please see Midatech Pharma page
Series C
3 employees
Biotechnology, Health and Wellness
FAQ About POP Biotechnologies
Unleash your inner particle. Test POP BIO's next-generation SNAP adjuvant system. Contact [email protected] for samples.
POP Biotechnologies was founded in 2015.
POP Biotechnologies is headquartered in Buffalo, United States.
POP Biotechnologies operates in Biotechnology, Health Care and Life Sciences. Its work centres on Nanotechnologies, Biomedical, Nanomedicine and Drug Delivery.
POP Biotechnologies has approximately 7 employees.
POP Biotechnologies has completed 3 funding rounds, raising a total of $4.70M. The latest funding stage is Seed.
Top alternatives and competitors to POP Biotechnologies include TLC BioSciences, Cytimmune Sciences, Q Chip Ltd - Now Midatech Pharma (Wales) Limited and part of Midatech Pharma plc, CEBIOTEX, ApoGen Biotechnologies, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
POP Biotechnologies and TLC BioSciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for POP Biotechnologies, https://bouncewatch.com/company/pop-biotechnologies, updated 25 November 2024. When citing, please name BounceWatch and link this page.
